赤座英之 (Hideyuki Akaza) - マイポータル - researchmap

基本情報

所属: 旧所属筑波大学人間総合科学研究科教授,附属病院総合がん診療センター長

学位: 医学博士(東京大学)

J-GLOBAL ID: 200901020228155704
researchmap会員ID: 1000048897

外部リンク: http://www.md.tsukuba.ac.jp/public/clinical-med/urology/

研究キーワード

2

研究分野

1

ライフサイエンス / 泌尿器科学 /

経歴

11

1997年

- 筑波大学臨床医学系泌尿器科教授
1997年

- Professor of the University of Tsukuba, Institute of Clinical Medicine
1990年 - 1996年

筑波大学臨床医学系泌尿器科助教授
1990年 - 1996年

Associate Professor of the University of Tsukuba
1986年 - 1990年

東京大学医学部泌尿器科講師
1986年 - 1990年

Lecturer of the University of Tokyo
1981年 - 1986年

東京大学医学部泌尿器科助手
1982年

- テネシー大学(USA)泌尿器科客員助教授
1982年

- Visiting assistant professor of University of Tennessee
1977年 - 1980年

東京大学医学部泌尿器科助手
1974年 - 1975年

東京大学医学部泌尿器科助手

学歴

2

- 1973年

東京大学, 医学部, 医学科
- 1973年

東京大学

委員歴

7

受賞

6

2009年

第41回がん研究助成金受賞
2007年

第13回中山恒明賞
2001年

Original contribution to "Doctors Progress to Science in Medical Science, University of Tsukuba, in 2000"
2001年

Original contribution to "Doctors Progress to Science in Medical Science, University of Tsukuba, in 2000"
1999年

第31回がん研究助成金賞
1982年

坂口賞

MISC

494

Real-time Elastography for the Diagnosis of Prostate Cancer: Evaluation of Elastographic Moving Images

Tomoaki Miyagawa, Masakazu Tsutsumi, Takeshi Matsumura, Natsui Kawazoe, Satoru Ishikawa, Tatsuro Shimokama, Naoto Miyanaga, Hideyuki Akaza

JAPANESE JOURNAL OF CLINICAL ONCOLOGY 39(6) 394-398 2009年6月
Evidence-based clinical practice guidelines for renal cell carcinoma (Summary - JUA 2007 Edition)

Tomoaki Fujioka, Wataru Obara

International Journal of Urology 16(4) 339-353 2009年4月
Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association

Eiji Kikuchi, Hiroyuki Fujimoto, Yoichi Mizutani, Eijiro Okajima, Hiroshi Koga, Shiro Hinotsu, Nobuo Shinohara, Mototsugu Oya, Tsuneharu Miki

INTERNATIONAL JOURNAL OF UROLOGY 16(3) 279-286 2009年3月
Immunoprotection against murine bladder carcinoma by octaarginine-modified liposomes incorporating cell wall of Mycobacterium bovis bacillus Calmette-GuErin

Akira Joraku, Atthachai Homhuan, Koji Kawai, Takahiro Yamamoto, Jun Miyazaki, Kentaro Kogure, Ikuya Yano, Hideyoshi Harashima, Hideyuki Akaza

BJU INTERNATIONAL 103(5) 686-693 2009年3月
DECREASE IN PROLIFERATION AND INCREASE IN DIFFERENTIATION IS ACCOMPANIED WITH LOW APAF-1 PROTEIN EXPRESSION IN TESTICULAR GERM CELL TUMOR PATHWAY

ElsevierJ Urol 181(supl 1-4) 200-201 2009年
EXPRESSION OF CADHERIN-6 MRNA IS POOR PROGNOSTIC FACTOR FOR PATIENTS WITH T1-T3 RENAL CELL CARCINOMA

ElsevierJ Urol 181(supl 1-4) 216-217 2009年
IDENTIFICATION OF PRETREATMENT PROGNOSTIC FACTOR FOR PATIENTS WITH INTERMEDIATE- AND POOR-RISK METASTATIC TESTICULAR CANCER

ElsevierJ Urol 181(supl 1-4) 198 2009年
FORKHEAD TRANSCRIPTION FACTOR FOXO1 IS INVOLVED IN PROGRESSION OF RENAL CELL CARCINOMA

J Urol 181(Supl 1-4) 106 2009年
RISK ASSESSMENT AMONG PROSTATE CANCER PATIENTS MANAGED WITH PRIMARY ANDROGEN DEPRIVATION THERAPY: A TRANSPACIFIC STUDY

ElsevierJ Urol 181(Supl 4-1) 103 2009年
Evidence-based clinical practice guidelines for renal cell carcinoma (Summary – JUA 2007 Edition)

Wiley InterScienceInt J Urol 16(4) 339-353 2009年
Bladder cancer develops 6 years earlier in current smokers: Analysis of bladder cancer registry data collected by the cancer registration committee of the Japanese Urological Association

Shiro Hinotsu, Hideyuki Akaza, Tsuneharu Miki, Hiroyuki Fujimoto, Nobuo Shinohara, Eiji Kikuchi, Yoichi Mizutani, Hirofumi Koga, Eijiro Okajima, Akihiko Okuyama

INTERNATIONAL JOURNAL OF UROLOGY 16(1) 64-69 2009年1月
Decreased expression of CXXC4 promotes a malignant phenotype in renal cell carcinoma by activating Wnt signaling

T. Kojima, T. Shimazui, S. Hinotsu, A. Joraku, T. Oikawa, K. Kawai, R. Horie, H. Suzuki, R. Nagashima, K. Yoshikawa …

ONCOGENE 28(2) 297-305 2009年1月
DECREASE IN PROLIFERATION AND INCREASE IN DIFFERENTIATION IS ACCOMPANIED WITH LOW APAF-1 PROTEIN EXPRESSION IN TESTICULAR GERM CELL TUMOR PATHWAY

ElsevierJ Urol 181(supl 1-4) 200-201 2009年
EXPRESSION OF CADHERIN-6 MRNA IS POOR PROGNOSTIC FACTOR FOR PATIENTS WITH T1-T3 RENAL CELL CARCINOMA

ElsevierJ Urol 181(supl 1-4) 216-217 2009年
IDENTIFICATION OF PRETREATMENT PROGNOSTIC FACTOR FOR PATIENTS WITH INTERMEDIATE- AND POOR-RISK METASTATIC TESTICULAR CANCER

ElsevierJ Urol 181(supl 1-4) 198 2009年
FORKHEAD TRANSCRIPTION FACTOR FOXO1 IS INVOLVED IN PROGRESSION OF RENAL CELL CARCINOMA

J Urol 181(Supl 1-4) 106 2009年
RISK ASSESSMENT AMONG PROSTATE CANCER PATIENTS MANAGED WITH PRIMARY ANDROGEN DEPRIVATION THERAPY: A TRANSPACIFIC STUDY

ElsevierJ Urol 181(Supl 4-1) 103 2009年
Evaluation of quality of life in patients with previously untreated advanced prostate cancer receiving maximum androgen blockade therapy or LHRHa monotherapy: a multicenter, randomized, double-blind, comparative study

Yoichi Arai, Hideyuki Akaza, Takashi Deguchi, Masato Fujisawa, Mikio Hayashi, Yoshihiko Hirao, Hiroshi Kanetake, Seiji Naito, Mikio Namiki, Masaaki Tachibana …

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY 134(12) 1385-1396 2008年12月
Clinical Practice Recommendations for the Management of Non–Muscle Invasive Bladder Cancer

Elsevier ScienceEur Urol 7(10) 651-666 2008年10月
Clinical Practice Recommendations for the Prevention and Management of Intravesical Therapy–Associated Adverse Events

Elsevier ScienceEur Urol 7(10) 667-674 2008年10月

もっとみる

書籍等出版物

54

PROSTATE CANCER Edition 2006

6th International Consultation on New Developments in Prostate Cancer and Prostate Diseases [Editions 21] 2006年
Developments in Cancer Epidemiology -Prospects for cancer control in the Asian pacific- [Extended abstracts for the 36th International Symposium of the Princess Takamatsu Cancer Research Fund, Tokyo, 2005]

the Princess Takamatsu Cancer Research Fund 2006年
PROSTATE CANCER Edition 2006

6th International Consultation on New Developments in Prostate Cancer and Prostate Diseases [Editions 21] 2006年
Developments in Cancer Epidemiology -Prospects for cancer control in the Asian pacific- [Extended abstracts for the 36th International Symposium of the Princess Takamatsu Cancer Research Fund, Tokyo, 2005]

the Princess Takamatsu Cancer Research Fund 2006年
Prostate Cancer: 3rd International Consultation of Prostate Cancer - Paris

Health Publications (distributor: Editions21) 2003年
Prostate Cancer: 3rd International Consultation of Prostate Cancer - Paris

Health Publications (distributor: Editions21) 2003年
Proceedings 2nd International Consultation on Prostate Cancer

Health Publication Ltd. 2000年
Proceedings 2nd International Consultation on Prostate Cancer

Health Publication Ltd. 2000年
Kidney cancer. recent results of basic and clinical research

Contrib Nephrol 1999年
Kidney cancer. recent results of basic and clinical research

Contrib Nephrol 1999年
Serum Creatinine Level during Chemotherapy for Testicular Cancer as a Possible Predictor of Bleomycin-induced Pulmonary Toxicity(共著)

In : Germ Cell Tumours IV, The Proceedings of the Fourth Germ Cell Tumour Conference, Published by : John Libbey & Co. Ltd. 1998年
4th International Consultation on Benign prostatic hyperplasia (BPH) Paris, July 2-5, 1997: Proceedings 4

Health Publication Ltd. 1998年
Serum Creatinine Level during Chemotherapy for Testicular Cancer as a Possible Predictor of Bleomycin-induced Pulmonary Toxicity(jointly worked)

In : Germ Cell Tumours IV, The Proceedings of the Fourth Germ Cell Tumour Conference, Published by : John Libbey & Co. Ltd. 1998年
4th International Consultation on Benign prostatic hyperplasia (BPH) Paris, July 2-5, 1997: Proceedings 4

Health Publication Ltd. 1998年
Food Factors for Cancer Prevention

Springer 1997年
Food Factors for Cancer Prevention

Springer 1997年
BCG intravesical instillation therapy as a first choice modality for existing sperficial bladder cancer

4th International Symposium on Recent Advances in Urological Cancer Diagnosis and Treatment Proceedings 4, Scientific Communication International Ltd. 1995年
Cancer chemotherapy : Challenges for the future volume 10

Excerpta Medica, Ltd. 1995年
BCG intravesical instillation therapy as a first choice modality for existing sperficial bladder cancer

4th International Symposium on Recent Advances in Urological Cancer Diagnosis and Treatment Proceedings 4, Scientific Communication International Ltd. 1995年
Cancer chemotherapy : Challenges for the future volume 10

Excerpta Medica, Ltd. 1995年

もっとみる

所属学協会

23

もっとみる

共同研究・競争的資金等の研究課題

8

前立腺癌のリスク評価と化学予防

科学研究費補助金
前立腺癌の環境・宿主要因に関する疫学的研究

科学研究費補助金
膀胱癌とBCGおよびBLP
前立腺癌の発癌に関する研究
膀胱癌の発癌に関する研究
Bladder cancer and BCG and BLP
Study of carcinogenesis of prostote cancer
Study of carcinogenesis of bladder cancer